ScholarIQanswers from OpenAlex & ORCID
Alexander M.M. Eggermont
ResearcherPublications, citations & collaboration network
Alexander M.M. Eggermont is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Alexander M.M. Eggermont have?
ScholarIQindexed works
Alexander M.M. Eggermont has 640 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Alexander M.M. Eggermont have?
ScholarIQcitation count
Alexander M.M. Eggermont has 60,848 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Alexander M.M. Eggermont?
ScholarIQh-index
Alexander M.M. Eggermont has an h-index of 104 in OpenAlex.
What is the i10-index of Alexander M.M. Eggermont?
ScholarIQi10-index
Alexander M.M. Eggermont has an i10-index of 385 in OpenAlex.
What is the ORCID of Alexander M.M. Eggermont?
ScholarIQorcid
The ORCID for Alexander M.M. Eggermont is on the source record.
What is the OpenAlex record for Alexander M.M. Eggermont?
ScholarIQopenalex
The OpenAlex for Alexander M.M. Eggermont is on the source record.
What are the most-cited papers on Alexander M.M. Eggermont?
ScholarIQmost cited works
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch, Jeffrey E. Gershenwald, Seng-Jaw Soong, John F. Thompson, Michael B. Atkins, David R. Byrd, Antônio C. Buzaid, Alistair J. Cochran, Daniel G. Coit, Shouluan Ding, Alexander M.M. Eggermont, Keith T. Flaherty, Phyllis A. Gimotty, John M. Kirkwood, Kelly M. McMasters, Martín C. Mihm, Donald L. Morton, Merrick I. Ross, Arthur J. Sober, Vernon K. Sondak
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
Alexander M.M. Eggermont, Christian U. Blank, Mario Mandalà, Georgina V. Long, Victoria Atkinson, Stéphane Dalle, Andrew Haydon, Mikhail Lichinitser, Adnan Khattak, Matteo S. Carlino, Shahneen Sandhu, James Larkin, Susana Puig, Paolo A. Ascierto, Piotr Rutkowski, Dirk Schadendorf, Rutger H.T. Koornstra, Leonel F. Hernandez‐Aya, Michele Maio, Alfonsus Johannes Maria van den Eertwegh, Jean-Jacques Grob, Ralf Gutzmer, Rahima Jamal, Paul Lorigan, Nageatte Ibrahim, Sandrine Marréaud, Alexander C. J. van Akkooi, Stefan Suciu, Caroline Robert
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
Chong Sun, Liqin Wang, Sidong Huang, Guus J.J.E. Heynen, Anirudh Prahallad, Caroline Robert, John B.A.G. Haanen, Christian U. Blank, Jelle Wesseling, Stefan M. Willems, Davide Zecchin, Sebastijan Hobor, Prashanth Kumar Bajpe, Cor Lieftink, Christina Mateus, Stéphan Vagner, Wipawadee Grernrum, Ingrid Hofland, Andreas Schlicker, Lodewyk F.A. Wessels, Roderick L. Beijersbergen, Alberto Bardelli, Federica Di Nicolantonio, Alexander M.M. Eggermont, René Bernards
The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes
Floris Dammeijer, Mandy van Gulijk, Evalyn E.A.P. Mulder, Melanie Lukkes, Larissa Klaase, Thierry van den Bosch, Menno van Nimwegen, Sai Ping Lau, Kitty Latupeirissa, Sjoerd Schetters, Yvette van Kooyk, Louis Boon, Antien Moyaart, Yvonne M. Mueller, Peter D. Katsikis, Alexander M.M. Eggermont, Heleen Vroman, Ralph Stadhouders, Rudi W. Hendriks, Jan H. von der Thüsen, Dirk J. Grünhagen, Cornelis Verhoef, Thorbald van Hall, Joachim G.J.V. Aerts
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016
Claus Garbe, Ketty Peris, Axel Hauschild, Philippe Saïag, Mark R. Middleton, Lars Bastholt, Jean‐Jacques Grob, Josep Malvehy, Julia Newton‐Bishop, Alexander Stratigos, Hubert Pehamberger, Alexander M.M. Eggermont